Buy Aurobindo Pharma; SL Rs 157, target Rs 174: Chopra

One can buy Aurobindo Pharma with a stop-loss of Rs 157 for the target of Rs 174, says Manav Chopra, Senior Technical Research Analyst at Nirmal Bang Securities.

Chopra told CNBC-TV18, "Aurobindo Pharma has been an out performing stock recently, and has been forming a series of higher highs and lows. The stock is also currently trading above its improtatn short-term averages. It has a strong support at Rs 158 on the downside. One can buy with a stop loss of Rs 157 with targets of Rs 174." The company's trailing 12-month (TTM) EPS was at Rs 20.40 per share. (Jun, 2012). The stock's price-to-earnings (P/E) ratio was 7.83. The latest book value of the company is Rs 85.64 per share. At current value, the price-to-book value of the company was 1.86. The dividend yield of the company was 0.63%. Disclosure: We may have some positions in the stocks we have discussed.